"Paradoxical" arthralgia occurring under anti-TNFα treatment for inflammatory bowel disease

Joint Bone Spine. 2018 Jan;85(1):133-134. doi: 10.1016/j.jbspin.2017.01.001. Epub 2017 Jan 20.

Authors

Maxime Sondag¹, Frank Verhoeven¹, Xavier Guillot¹, Clément Prati¹, Charline Briot², Lucine Vuitton², Stéphane Koch², Daniel Wendling³

Affiliations

¹ Department of Rheumatology, University Teaching Hospital, CHRU, 25030 Besançon, France.
² Department of Gastro-enterology, University Teaching Hospital, CHRU, 25030 Besançon, France.
³ Department of Rheumatology, University Teaching Hospital, CHRU, 25030 Besançon, France. Electronic address: [email protected].

PMID: 28115270
DOI: 10.1016/j.jbspin.2017.01.001

No abstract available

Keywords: Inflammatory bowel disease; Infliximab trough level; Methotrexate; Paradoxical arthralgia; Spondyloarthritis; TNF blockers.

Publication types

Letter

MeSH terms

Adalimumab / adverse effects*
Adalimumab / therapeutic use
Antibodies, Monoclonal / adverse effects*
Antibodies, Monoclonal / therapeutic use
Antirheumatic Agents / adverse effects
Antirheumatic Agents / therapeutic use
Arthralgia / chemically induced*
Arthralgia / diagnosis
Drug Therapy, Combination
Female
Humans
Inflammatory Bowel Diseases / drug therapy*
Infliximab / adverse effects*
Infliximab / therapeutic use
Male
Middle Aged
Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

Antibodies, Monoclonal
Antirheumatic Agents
Tumor Necrosis Factor-alpha
golimumab
Infliximab
Adalimumab